Infectious Diseases

  • Management of neglected tropical diseases now and in the future

    Management of neglected tropical diseases now and in the future

    What are the most important advances in the diagnosis, treatment, and prevention of tropical diseases in the past years? Can we expect any breakthrough in the treatment of neglected tropical diseases?

  • Epidemiologic changes in the post-COVID-19 era

    Epidemiologic changes in the post-COVID-19 era

    During the COVID-19 pandemic, many countries experienced difficulties in implementing vaccination programs and other infectious disease control measures. This affected the epidemiology of some diseases, with increase in the global number of malaria cases being an example. How significant are these epidemiologic changes for clinical practice?

  • Clues for the diagnostic workup in travelers with fever returning from the tropics

    Clues for the diagnostic workup in travelers with fever returning from the tropics

    What would you advise to your inexperienced colleagues faced with a febrile patient returning from tropical countries? What clues from the history and physical examination findings may suggest a potentially life-threatening infection in such patients?

  • Long COVID and pain

    Long COVID and pain

    What type of pain is most prevalent in long COVID and how to manage it?

  • Important recent reports in infectious diseases

    Important recent reports in infectious diseases

    Have there been any breakthrough reports or any new important guidelines in the field of infectious diseases?

  • N95 respirators versus medical masks in viral infections transmitted by inhalation

    N95 respirators versus medical masks in viral infections transmitted by inhalation

    Is it already known which are better in providing medical care to those infected with SARS-CoV-2: medical masks or N95 respirators? Should we recommend the use of N95 respirators by immunosuppressed patients in the setting of increased exposure to pathogens transmitted by inhalation, including SARS-CoV-2?

  • Mechanisms of long COVID

    Mechanisms of long COVID

    Following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, many people develop long COVID with various clinical manifestations. What is known about the etiology and pathogenesis of long COVID? Is the mechanism similar, to, for example, chronic fatigue syndrome after other infections? Is it possible to shorten the duration of long COVID symptoms?

  • Aspergillosis screening and treatment in patients with neutropenia

    Aspergillosis screening and treatment in patients with neutropenia

    Should patients with neutropenia be screened for aspergillosis, eg, with periodic galactomannan testing? Is a positive galactomannan test result without abnormal radiologic findings an indication to initiate treatment in a patient with neutropenia?

  • Mold infections in immunosuppressed individuals

    Mold infections in immunosuppressed individuals

    When to include a fungal infection in the differential diagnosis in an immunosuppressed patient?

  • Antibacterial prophylaxis in patients with neutropenia

    Antibacterial prophylaxis in patients with neutropenia

    When should patients with neutropenia receive antibiotics for infection prevention? Which agents and regimens should be used? Should antibiotics be used in patients with extreme non-chemotherapy-induced neutropenia who are not more prone to infections than the general population?

74 articles - page 1 of 8

We would love to hear from you

Comments, mistakes, suggestions?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.